Elad Sharon(@EladSharonMD) 's Twitter Profile Photo

Honored to receive a plaque for our team’s work getting the first immune checkpoint inhibitor approved in ! is a rare cancer! Thanks for this Dr. Monica M. Bertagnolli’s award! My last for work I did NCI CTEP Clinical Research! Thanks to @NIH, Genentech & FDA Oncology

Honored to receive a plaque for our team’s work getting the first immune checkpoint inhibitor approved in #sarcoma! #AlveolarSoftPartSarcoma is a rare cancer! Thanks for this @NIHDirector’s award! My last for work I did @NCICTEP_ClinRes! Thanks to @NIH, @genentech & @FDAOncology
account_circle
Vivek Subbiah, MD(@VivekSubbiah) 's Twitter Profile Photo

In 2017➡️we reviewed all advanced sarcoma patients on Phase 1 trials. We concluded that was the only experiencing Partial Response
In 2022 ➡️ was FDA approved for this OncoAlert
jitc.bmj.com/content/5/1/100

In 2017➡️we reviewed all advanced sarcoma patients on Phase 1 #immunotherapy trials. We concluded that #alveolarsoftpartsarcoma was the only #sarcoma experiencing Partial Response 
In 2022 ➡️#immunotherapy was FDA approved for this #rarecancer @OncoAlert 
jitc.bmj.com/content/5/1/100
account_circle
Matt Hemming(@SarcomaLab) 's Twitter Profile Photo

Now out in Cancer Research: We mine the epigenetic underpinnings of utilizing patient samples, preclinical models, and functional tags (dTAG, BioID) to define the oncogenic transcriptional program driven by ASPSCR1::TFE3 and actionable therapeutic liabilities:

account_circle
Sarcoma UK(@Sarcoma_UK) 's Twitter Profile Photo

This image shows another case of , fluorescently stained for multiple immune cell types (T cells and macrophages) on the same slide, showing how the immune and cells interact (3/3)

This image shows another case of #AlveolarSoftPartSarcoma, fluorescently stained for multiple immune cell types (T cells and macrophages) on the same slide, showing how the immune and #Sarcoma cells interact (3/3)
account_circle
Sarcoma UK(@Sarcoma_UK) 's Twitter Profile Photo

Ultra-rare subtypes that I work on include & . Many of these subtypes aren't well understood, are challenging to diagnose & have limited therapy options available (2/3)

Ultra-rare #Sarcoma subtypes that I work on include #AlveolarSoftPartSarcoma & #EpithelioidHaemangioendothelioma. Many of these subtypes aren't well understood, are challenging to diagnose & have limited therapy options available (2/3)
account_circle
Maddie Cowey(@CoweyMaddie) 's Twitter Profile Photo

Just your local sarcoma patient here proud of her input into the 100,000 genomes project 🙌

They took my blood just before my first surgery

It was my first ever blood test

Nearly fainted in the corridor

account_circle
Clinical Cancer Research(@CCR_AACR) 's Twitter Profile Photo

of VEGFR TKIs and in aggressive did not meet its endpoints for ORR. Nguyen et al describe the study and potential reasons for the low response rate. bit.ly/3QggnYb Naoko Takebe; @albirunirazak; Geraldine O'Sullivan Coyne

#ClinicalTrial of VEGFR TKIs #cediranib and #sunitinib in aggressive #AlveolarSoftPartSarcoma did not meet its endpoints for ORR. Nguyen et al describe the study and potential reasons for the low response rate. bit.ly/3QggnYb @NaokoTakebe; @albirunirazak; @geosullivanc
account_circle
Sarcoma Alliance(@SarcomaAlliance) 's Twitter Profile Photo

Video interview with sarcoma expert Dr. Jonathan Trent ( Jon Trent, MD, PhD ) discusses recent advances in treatment, especially immunotherapy for . immunotherapy
youtube.com/watch?v=BDwHza…

account_circle
Cliff Sullivan(@DrCliffSullivan) 's Twitter Profile Photo

AlveolarSoftPartSarcoma:der(17)t(X;17)ASPSCR1/TFE3 [Alvin the chipmunk Shares Part of his Seeds with 17 of his eX’s named TiFany]

account_circle